RespiQ
Smart breath testing for better health.
The Netherlands
11 employees
Grant
Total: $4.21M
Biotechnology
General Information
Get notified when RespiQ moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Discover More
The Netherlands Market
Biotechnology
About RespiQ
Taxonomy: HealthTech, Breath analysis, AI-enhanced sensor, Disease diagnosis, Health monitoring, Non-invasive, Metabolic disease, Respiratory disease, Cancer, Cardiovascular disease, Inflammatory disease, Infectious disease, Personalized health insights, Biometric analysis, Medical technology
Funding Rounds & Investors (3)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Grant | •••••• | 1 |
|
20 Nov 2023 |
| Pre Seed Round | •••••• | 1 |
|
26 Aug 2019 |
| Seed Round | •••••• | - | 01 Jan 2019 |
Latest News
View All
RespiQ Alternatives & Competitors
Disruptive technology for rapid non-invasive, real-time diagnosis
-logo.jpg "Spirometrix, Inc. (now Spirosure, Inc.)"){kind=logo}
Innovative breath-analysis devices for non-invasive management of chronic respiratory diseases throu...
On a mission to save 100k lives and $1.5B healthcare costs
FAQ About RespiQ
Don't just browse. Track.
Signal Tracker monitors RespiQ and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.